Lechlemer

N/A

Report date: 2024/04/28 11:22:41
NME

Base Information

Drug NameLechlemer
Drug Alias NameSB-300NP-300
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionChloride channel antagonists
TargetsChloride channel
Therapy Area/IndicationsDiarrheaCholera
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesNapo Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesJaguar HealthNapo EU SPANapo Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiarrheaCholera
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A